“Ocrelizumab-induced Psoriasis in A Patient with Relapsing-Remitting Multiple Sclerosis” (2023) European Journal of Medical and Health Sciences, 5(3), pp. 1–2. doi:10.24018/ejmed.2023.5.3.1697.